Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Cellular Biomedicine Raises $10 Million in Private Placement

publication date: Jul 16, 2014
Cellular Biomedicine Group of California raised $10 million through a private placement led by Hong Kong investment banker Francis Leung. CBMG is a cell therapy company that is developing three products for the China market. For serving as lead investor, Mr. Leung has a three-year option to buy an additional 1 million shares at $8 each. If the stock trades above $12 for 20 consecutive trading days, CBMG has the right to compel the purchase. That may happen soon. More details....

Stock Symbol: (NSDQ: CBMG)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital